18-31074784-G-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_024422.6(DSC2):c.1787C>T(p.Ala596Val) variant causes a missense change. The variant allele was found at a frequency of 0.000827 in 1,613,922 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A596A) has been classified as Likely benign.
Frequency
Consequence
NM_024422.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.1787C>T | p.Ala596Val | missense_variant | 12/16 | ENST00000280904.11 | NP_077740.1 | |
DSC2 | NM_004949.5 | c.1787C>T | p.Ala596Val | missense_variant | 12/17 | NP_004940.1 | ||
DSC2 | NM_001406506.1 | c.1358C>T | p.Ala453Val | missense_variant | 12/16 | NP_001393435.1 | ||
DSC2 | NM_001406507.1 | c.1358C>T | p.Ala453Val | missense_variant | 12/17 | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.1787C>T | p.Ala596Val | missense_variant | 12/16 | 1 | NM_024422.6 | ENSP00000280904 | P1 | |
DSC2 | ENST00000251081.8 | c.1787C>T | p.Ala596Val | missense_variant | 12/17 | 1 | ENSP00000251081 | |||
DSC2 | ENST00000648081.1 | c.1358C>T | p.Ala453Val | missense_variant | 13/17 | ENSP00000497441 | ||||
DSC2 | ENST00000682357.1 | c.1358C>T | p.Ala453Val | missense_variant | 12/16 | ENSP00000507826 |
Frequencies
GnomAD3 genomes AF: 0.000750 AC: 114AN: 152044Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00119 AC: 298AN: 251052Hom.: 1 AF XY: 0.00139 AC XY: 189AN XY: 135680
GnomAD4 exome AF: 0.000835 AC: 1221AN: 1461760Hom.: 6 Cov.: 32 AF XY: 0.000974 AC XY: 708AN XY: 727166
GnomAD4 genome AF: 0.000743 AC: 113AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.000780 AC XY: 58AN XY: 74372
ClinVar
Submissions by phenotype
not provided Benign:6
Likely benign, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 03, 2020 | This variant is associated with the following publications: (PMID: 26656175, 25163546, 23396983, 23861362, 20031617, 20857253, 25351510, 28600387, 33232181) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | DSC2: BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not specified Benign:4
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 07, 2017 | p.Ala596Val in exon 12 of DSC2: This variant is not expected to have clinical si gnificance because it has been identified in 0.3% (49/16468) of South Asian chro mosomes, including 1 homozygous individual, by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP dbSNP rs148185335). - |
Likely benign, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | Dec 22, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 12, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Arrhythmogenic right ventricular dysplasia 11 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Feb 09, 2018 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Cardiomyopathy Benign:2
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Sep 09, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 09, 2018 | - - |
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Aug 10, 2015 | - - |
DSC2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 14, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 28, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at